Literature DB >> 15733499

Resistant hepatic hydrothorax: a successful case with treatment by nCPAP.

Ken-ichi Takahashi1, Kazuo Chin, Kensuke Sumi, Takaya Nakamura, Hisako Matsumoto, Akio Niimi, Iwao Ikai, Michiaki Mishima.   

Abstract

Hepatic hydrothorax is defined as pleural effusion with liver cirrhosis but no primary cardiopulmonary disease. Hepatic hydrothorax is often resistant to various therapeutic interventions. The most likely cause is the transfer of ascites fluid from the abdomen to the pleural space via the diaphragm because of a negative intrathoracic pressure gradient. A 62-year-old man was diagnosed with hepatoma and cirrhosis. After a partial hepatectomy, he suffered with hepatic hydrothorax. He had snoring without obvious sleep apnea. The patient's hepatic hydrothorax markedly improved following nasal continuous positive airway pressure (nCPAP) treatment during sleep. The mechanism for the improvement may have been the intrathoracic positive pressure during sleep induced by the nCPAP treatment during sleep. nCPAP treatment may provide a new therapy for resistant hepatic hydrothorax.

Entities:  

Mesh:

Year:  2005        PMID: 15733499     DOI: 10.1016/j.rmed.2004.08.001

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  2 in total

1.  Predictive factors for reintubation following noninvasive ventilation in patients with respiratory complications after living donor liver transplantation.

Authors:  Yuichi Chihara; Hiroto Egawa; Toru Oga; Tomomasa Tsuboi; Tomohiro Handa; Shintaro Yagi; Taku Iida; Atsushi Yoshizawa; Kazuhiko Yamamoto; Michiaki Mishima; Koichi Tanaka; Shinji Uemoto; Kazuo Chin
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

Review 2.  Pleural effusion from intrathoracic migration of a ventriculo-peritoneal shunt catheter: pediatric case report and review of the literature.

Authors:  Federica Porcaro; Emidio Procaccini; Maria Giovanna Paglietti; Alessandra Schiavino; Francesca Petreschi; Renato Cutrera
Journal:  Ital J Pediatr       Date:  2018-03-27       Impact factor: 2.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.